Tuesday, August 9News That Matters
Shadow

Tag: approved

Moderna becomes third Covid vaccine approved in the UK

Moderna becomes third Covid vaccine approved in the UK

Health
.css-94m6rd-HeadingWrapper{border-bottom:solid 1px #BABABA;padding-bottom:1.5rem;}.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}.css-vk3nhx-ComponentWrapper{margin:1.5rem 0;}.css-2y05cd-StyledFigure{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;}.css-kwaqyc-StyledFigureContainer{position:relative;}.css-1xtcmof-Placeholder{position:relative;display:block;padding-bottom:56.25%;background-color:#EEEEEE;}.css-1xtcmof-Placeholder img{overflow:hidden;position:absolute;top:0;right:0;bottom:0;left:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webki...
Covid-19: Oxford-AstraZeneca vaccine approved for use in UK

Covid-19: Oxford-AstraZeneca vaccine approved for use in UK

Health
.css-94m6rd-HeadingWrapper{border-bottom:solid 1px #BABABA;padding-bottom:1.5rem;}.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}.css-18mjolk-ComponentWrapper{margin:1.5rem 0;max-width:50rem;}.css-2y05cd-StyledFigure{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;}.css-kwaqyc-StyledFigureContainer{position:relative;}.css-1uy4vn0-Container{height:0;padding-bottom:56.25%;width:100%;color:#3F3F42;background-color:#EEEEEE;}.css-1d84lqw-LogoIconWrapper{width:30%;padding-top:23.868243243243246%;margin:0 auto;color:#3F3F42;opacity:0.2;}.css-1rnnz6t-StyledFigureCaption{background:#3F3F42;color:#EEEEEE;padding:1rem;}.css-uf6wea-RichTextComponentWrapper{margin:1rem 0;max-width:36...
Covid-19: Pfizer/BioNTech vaccine approved for use next week in UK

Covid-19: Pfizer/BioNTech vaccine approved for use next week in UK

Health
.css-94m6rd-HeadingWrapper{border-bottom:solid 1px #BABABA;padding-bottom:1.5rem;}.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}.css-vk3nhx-ComponentWrapper{margin:1.5rem 0;}.css-1759m9z-StyledFigure{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;}.css-kwaqyc-StyledFigureContainer{position:relative;}.css-1xtcmof-Placeholder{position:relative;display:block;padding-bottom:56.25%;background-color:#EEEEEE;}.css-1xtcmof-Placeholder img{overflow:hidden;position:absolute;top:0;right:0;bottom:0;left:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webk...
Romania approved for F-16 upgrades in $175.4M deal

Romania approved for F-16 upgrades in $175.4M deal

Business
Nov. 4 (UPI) -- The U.S. State Department approved the sale of upgrades to the F-16 fighter planes of Romania's air force, the Defense Security Cooperation Agency announced. The $ 175.5 million deal, with Lockheed Martin as its principal contractor, is expected to be approved by the U.S. Senate, the agency said Tuesday in a press release. Advertisement The deal includes itemized upgrades to the avionics, software, communication equipment, navigational aids, and cockpit of the F-16AMs in the Romanian Air Force. Among the specific upgrades are Global Positioning Systems, Multifunctional Information Distribution System Joint Tactical Radio Systems, Advanced Identification Friend or Foe systems and cryptography equipment, DSCA said. Romania, a NATO member since 2004, has 16 F-16 variants in i...
FDA approved opioids for chronic pain despite lacking ‘critical’ safety data, analysis finds

FDA approved opioids for chronic pain despite lacking ‘critical’ safety data, analysis finds

Health
Sept. 28 (UPI) -- The U.S. Food and Drug Administration approved nearly 50 new prescription opioid pain medications between 1997 and 2018, even though it lacked "critical" data on safety and effectiveness, an analysis published Monday by the journal Annals of Internal Medicine found. None of the 48 drugs granted agency approval during the more than 20-year period was evaluated in clinical trials that lasted longer than 12 weeks, and the trials often included narrowly defined groups of patients, researchers said. Advertisement And few included "systematic assessments" of risks associated with these medications, including addiction potential and non-medical use. "Our analysis provides a window through which to view the FDA's opioid regulation over the past 20 years," study co-author Dr. Cal...